Homburger assisted AMAG Leasing, a Swiss car leasing services company, to successfully complete the issuance of CHF 100 m 1.625 per cent. Bonds. The fixed-income securities will eventually mature in 2028. AMAG Leasing’s is the subsidiary of
Tags :Stefan Oesterhelt
Homburger acted as legal advisor to UBS Switzerland in its role as mandated lead arranger, sole underwriter, bookrunner, agent, security agent, and original lender for the financing of United Grinding Group’s acquisition of GF
Homburger advised Noema Pharma, a clinical-stage biotech company, on its successful closing of a Series B extension financing round with an investment from EQT Life Sciences, and with continued support from Jeito and Forbion, all
Walder Wyss advised Bank J. Safra Sarasin on the acquisition of 100% of the shares of MIV Asset Management(MIV), a medical technology investment fund advised by Homburger. MIV will maintain its existing investment strategy and
Homburger advised EQT, leader of the SwissCo consortium, in the transaction. Meanwhile, Niederer Kraft Frey represented the banking syndicate consisting of Citi, Goldman Sachs, Jefferies, Morgan Stanley, and UBS. SwissCo, together with the Abu Dhabi
Homburger advised Alchemy US on the renewal of its credit financings. The firm entered into a term loan credit agreement with HPS Investment as a term loan agent. The firm also entered into an asset-based
Homburger acts as counsel to SIX Group in connection with the contemplated acquisition of Aquis Exchange, which was announced on November 11, 2024. SIX Group operates a fully integrated exchange value chain across the Swiss and Spanish
On October 25, 2024, Homburger advised Molecular Partners, a clinical-stage biotechnology company, in the announcement of the pricing of an underwritten public offering. The offering consisted of 3,642,988 American Depositary Shares (ADSs), representing new shares, priced at $5.49 per
Homburger advised Elanco in Switzerland on any aspect of Swiss law within the transaction. The background On the 13th of August 2024, Elanco Animal Health and Elanco US entered into an incremental assumption agreement to obtain
Homburger, on October 24, 2024, advised Avolta on a refinancing deal of its revolving credit facility (RCF). The amended EUR 2,400 m RCF with maturity in 2029 replaces the EUR 2,750 m RCF expiring in 2027. Avolta Avolta is a Swiss-based
